Leaf Expression Systems specializes in plant-based expression technologies, particularly through their proprietary SupraVec® technology. This innovative platform enables the production of recombinant proteins, which are essential for various applications in research and development, including therapeutic drug development, diagnostics, and vaccine production. By leveraging plant biotechnology, the company aims to enhance the efficiency and affordability of drug manufacturing, thereby accelerating the delivery of new treatments to patients. Their services encompass a wide range of capabilities, including plant engineering, gene overexpression, and high-throughput screening, all designed to support partners in their research endeavors.

In addition to therapeutic applications, Leaf Expression Systems is committed to addressing challenges in agriculture and food production. They collaborate with partners to develop robust crops that can withstand environmental stresses such as drought and disease, contributing to food security in a changing climate. Their offerings extend to the food industry, where they provide cruelty-free growth factors and cytokines, as well as to the consumer care sector, focusing on sustainable and ethical plant-based products. Through these initiatives, Leaf Expression Systems aims to foster innovation and drive positive impacts across various industries.

United Kingdom

Leaf Expression Systems is a translational R&D and contract manufacturing business focused on the plant expression of proteins, vaccines, and complex natural products. They use the power of plant-based expression and plant biotechnology to enable their partners to innovate and impact, helping to drive their productivity and create.

Leaf Expression Systems

Company Details